Differentiation of Oligodendrocyte Progenitor Cells from Human Embryonic Stem Cells on Vitronectin-Derived Synthetic Peptide Acrylate Surface
Authors:
- 18 December 2012
- journal article
- research article
- Published by SAGE Publications in Stem Cells and Development
- Vol. 22 (10) , 1497-1505
Abstract
Human embryonic stem cell (hESC)-derived oligodendrocyte progenitor cells (OPCs) are being studied for cell replacement therapies, including the treatment of acute spinal cord injury. Current methods of differentiating OPCs from hESCs require complex, animal-derived biological extracellular matrices (ECMs). Defined, low-cost, robust, and scalable culture methods will need to be developed for the widespread deployment and commercialization of hESC-derived cell therapies. Here we describe a defined culture system that uses a vitronectin-derived synthetic peptide acrylate surface (VN-PAS; commercially available as Corning ® Synthemax ® surface) in combination with a defined culture medium for hESC growth and differentiation to OPCs. We show that synthetic VN-PAS supports OPC attachment and differentiation, and that hESCs grown on VN-PAS are able to differentiate into OPCs on VN-PAS. Compared to OPCs derived from hESCs grown on ECM of animal origin, higher levels of NG2, a chondroitin sulfate proteoglycan expressed by OPCs, were observed in OPCs differentiated from H1 hESCs grown on VN-PAS, while the expression levels of Nestin and PDGFRα were comparable. In summary, this study demonstrates that synthetic VN-PAS can replace complex, animal-origin ECM to support OPC differentiation from hESCs.Keywords
This publication has 48 references indexed in Scilit:
- A synthetic substrate to support early mesodermal differentiation of human embryonic stem cellsBiomaterials, 2011
- Cellular Treatments for Spinal Cord Injury: The Time is Right for Clinical TrialsNeurotherapeutics, 2011
- Engineered polymer-media interfaces for the long-term self-renewal of human embryonic stem cellsBiomaterials, 2011
- Chemically defined conditions for human iPSC derivation and cultureNature Methods, 2011
- Concise Review: Bone Marrow for the Treatment of Spinal Cord Injury: Mechanisms and Clinical ApplicationsStem Cells, 2011
- Long-term human pluripotent stem cell self-renewal on synthetic polymer surfacesBiomaterials, 2010
- A defined glycosaminoglycan-binding substratum for human pluripotent stem cellsNature Methods, 2010
- Synthetic polymer coatings for long-term growth of human embryonic stem cellsNature Biotechnology, 2010
- High-Throughput Discovery of Synthetic Surfaces That Support Proliferation of Pluripotent CellsJournal of the American Chemical Society, 2010
- Characterization and culture of human embryonic stem cellsNature Biotechnology, 2005